ERCC6 and gastric cancer: The high expression of ERCC4 mRNA was associated with shorter OS for GC patients who underwent surgery only, whereas a high expression of ERCC6 mRNA was associated with poor OS for GC patients treated with 5-FU-based adjuvant and surgery.